Updates, milestones, and links shared by Cartwheel.
Signed LOI to market Clearsight's OTC pink eye drop under Cartwheel brand
Additional testing completed on lice in the laboratory when exposed to heat and CO2 showing 100% mortality rates. Sample of one group of the tests below - but there were many more.
Exclusive license to technology behind patents US10328112B2 | CA3025269C | EP3492063B1
Very positive pre-sub meeting with the device section of the FDA. They had no objections to our proposed predicate device, clinical trial plan, or regulatory path of Class I, 510(k).